Preferential Relative Porphyrin Enrichment in Solar Keratoses upon Topical Application of δ-Aminolevulinic Acid Methylester

Photochemistry and Photobiology

Volumn 68, Issue 2, 1998, Pages 218-221

  Fritsch, Clemens ^a   Homey, Bernhard ^a   Stahl, Wilhelm ^a   Lehmann, Percy ^a   Ruzicka, Thomas ^a   Sies, Helmut ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

AMINOLEVULINIC ACID; DELTA AMINOLEVULINIC ACID METHYL ESTER; DELTA-AMINOLEVULINIC ACID METHYL ESTER; DRUG DERIVATIVE; PHOTOSENSITIZING AGENT; PORPHYRIN;

ANIMAL; ARTICLE; BIOLOGY; HUMAN; IN VITRO STUDY; KERATOSIS; METABOLISM; PHOTOCHEMOTHERAPY; SUNLIGHT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANIMALS; HUMANS; KERATOSIS; PHOTOBIOLOGY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SUNLIGHT;

EID: 0032134970     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.1998.tb02492.x     Document Type: Article

References (22)

1. Kennedy, J. C., R. H. Pottier and D. C. Pross (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B Biol. 6, 143-148.
2. Pass, H. I. (1993) Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst. 85, 443-453.
3. Wolf, P., E. Rieger and H. Kerl (1993) Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J. Am. Acad. Dermatol. 28, 17-21.
4. Calzavara-Pinton, P. G. (1995) Repetitive photodynamic therapy with topical δ-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J. Photochem. Photobiol. B Biol. 29, 53-57.
5. Fritsch, C., P. M. Becker-Wegerich, K. W. Schulte, W. Neuse, P. Lehmann, T. Ruzicka and G. Goerz (1996) Treatment of a large superficial basal cell carcinoma of the breast with combination of photodynamic therapy and surgery controlled by photodynamic diagnosis. Hautarzt 47, 438-442.
6. Fritsch, C., G. Goerz and T. Ruzicka (1998) Photodynamic therapy in dermatology. A review. Arch. Dermatol. 134, 207-214.
7. Fritsch, C., B. Verwohlt, K. Bolsen, T. Ruzicka and G. Goerz (1996) Influence of topical photodynamic therapy with 5-aminolevulinic acid on the porphyrin metabolism. Arch. Dermatol. Res. 288, 517-521.
8. Fritsch, C., W. Stahl, K. W. Schulte, H. Sies, G. Goerz, L. P. Lehmann and T. Ruzicka (1998) Optimum porphyrin formation in skin tumors and psoriasis lesions after topical application of δ-aminolevulinic acid. J. Invest. Dermatol. 110, 673.
9. Peng, Q., J. Moan, T. Warloe, V. Iani, H. B. Steen, A. Bjorseth and J. M. Nesland (1996) Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J. Photochem. Photobiol. B Biol. 34, 95-96.
10. Martin, A., W. D. Tope, J. M. Grevelink, J. C. Starr, J. L. Fewkes, T. J. Flotte, T. F. Deutsch and R. R. Anderson (1995) Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulimc acid: implications for photodynamic therapy. Arch. Dematol. Res. 287, 665-674.
11. Szeimies, R. M., T. Sassay and M. Landthaler (1994) Penetration potency of topical applied delta aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem. Photobiol. 59, 73-76.
12. Peng, Q., T. Warloe, J. Moan, H. Heyerdahl, H. B. Steen, J. M. Nesland and K.-E. Giercksky (1995) Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem. Photobiol. 62, 906-913.
13. Fritsch, C., C. Abels, G. Goetz, W. Stahl, K. Bolsen, T. Ruzicka, G. Goerz and H. Sies (1997) Porphyrins preferentially accumulate in a melanoma following intravenous injection of 5-aminolevulinic acid. Biol. Chem. 378, 51-57.
14. Lowry, O. H., N. J. Rosenbrough, A. L. Farr and R. J. Randall (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
15. Seubert, A. and S. Seubert (1982) High-performance liquid chromatographic analysis of porphyrins and their isomers with radial compression columns. Anal. Biochem. 124, 303-307.
16. Fritsch, C., J. Batz, K. Bolsen, K. W. Schulte, M. Zumdick, T. Ruzicka and G. Goerz (1997) Ex vivo application of ALA induces high and specific porphyrin levels in human skin tumors. Possible basis for selective photodynamic therapy. Photochem. Photobiol. 66, 114-118.
17. Warloe, T., Q. Peng, H. B. Steen and K. E. Giercksky (1992) Localization of porphyrins in human basal cell carcinoma and normal skin tissue induced by topical application of 5-aminolevulinic acid. In Photodynamic Therapy and Biomedical Lasers. (Edited by P. Spinelli, M. Del Fante and R. Marchesini), pp. 454-458. Elsevier, Amsterdam.
18. Stringer, M. R., P. Collins, D. J. Robinson, G. I. Stables and R. A. Sheehan-Dare (1996) The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for photodynamic therapy. J. Invest. Dermatol. 107, 76-81.
19. Malik, Z., G. Kostenich, L. Roitman, B. Ehrenberg and A. Orenstein (1995) Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice. J. Photochem. Photobiol. B Biol. 28, 213-218.
20. Gaullier, J. M., K. Berg, Q. Peng, H. Anholt, P. K. Selbo, L. W. Ma and J. Moan (1997) Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in cuture. Cancer Res. 57, 1481-1486.
21. Kriegmair, M., R. Baumgartner, R. Knüchel, H. Stepp, F. Hofstädter and A. Hofstetter (1996) Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J. Urol. 155, 105-109.
22. Fritsch, C., K. Kalka, P. Lehmann, K. W. Schulte, W. Neuse, T. Ruzicka and G. Goerz (1997) Fluorescence detection of δ-aminolevulinic acid-induced porphyrins (photodynamic diagnosis) in dermatology. Z. Hautkr. H+G 8, 570-576.